Medical Condition Osteoporosis

Source:

2009 icd-9-cm diagnosis 733.0 - osteoporosis

Active Ingredients used for Osteoporosis:

Black Tea, Boron, Copper, Evening Primrose Oil, Horsetail, Omega 3 Fatty Acids Fish Oil Alpha Linolenic Acid, Soy, Vitamin D, Vitamin K

Active Ingredient	Uses based on scientific evidence	Grade*
black tea (camellia sinensis)	preliminary research suggests that chronic use of black tea may improve bone mineral density (bmd) in older women. better research is needed in this area before a conclusion can be drawn.	c
boron	animal and preliminary human studies report that boron may play a role in mineral metabolism, with effects on calcium, phosphorus, and vitamin d. however, research of bone mineral density in women taking boron supplements does not clearly demonstrate benefits in osteoporosis. additional study is needed before a firm conclusion can be drawn.	c
copper	osteopenia and other abnormalities of bone development related to copper deficiency may occur in copper-deficient low-birth weight infants and young children. supplementation with copper may be helpful in the treatment and/or prevention of osteoporosis, although early human evidence is conflicting. the effects of copper deficiency or copper supplementation on bone metabolism and age-related osteoporosis require further research before clear conclusions can be drawn.	c
evening primrose oil (oenothera biennis l.)	primrose oil has been suggested as a possible treatment for bone loss/osteoporosis. however, osteoporosis studies using primrose oil as a treatment are lacking. well-designed human trials are needed before primrose oil can be recommended for osteoporosis therapy.	c
horsetail (equisetum arvense l.)	silicon may be beneficial for bone strengthening. because horsetail contains silicon, it has been suggested as a possible natural treatment for osteoporosis. preliminary human study reports benefits, but more detailed research is needed before a firm recommendation can be made. people with osteoporosis should speak with a qualified healthcare provider about possible treatment with more proven therapies.	c
omega-3 fatty acids, fish oil, alpha-linolenic acid	early evidence suggests that plant sources of dietary n-3 pufa may help protect against bone loss. more research is needed to confirm these findings.	c
soy (glycine max [l. merr.)]	it has been theorized that "phytoestrogens in soy" (such as isoflavones) may increase bone mineral density in post-menopausal women and reduce the risk of fractures. however, more research is needed before a conclusion can be made.	c
vitamin d	without sufficient vitamin d, inadequate calcium is absorbed and the resulting elevated parathyroid (pth) secretion causes increased bone resorption. this may weaken bones and increase the risk of fracture. vitamin d supplementation has been shown to slow bone loss and reduce fracture, particularly when taken with calcium.	b
vitamin d	osteoporosis is common in patients with cystic fibrosis (due to fat malabsorption, which leads to a deficiency of fat-soluble vitamins such as vitamin d). oral calcitriol administration appears to increase the absorption of calcium and decrease parathyroid concentrations.	c
vitamin k	vitamin k appears to prevent bone resorption and adequate dietary intake is likely necessary to prevent excess bone loss. elderly or institutionalized patients may be at particular risk and adequate intake of vitamin k-rich foods should be maintained. unless patients have demonstrated vitamin k deficiency, there is no evidence that additional vitamin k supplementation is helpful. some studies show that vitamin k supplements may increase bone mineral density and bone strength, while others show	c

*Key to grades
A: Strong scientific evidence for this use;
B: Good scientific evidence for this use;
C: Unclear scientific evidence for this use;
D: Fair scientific evidence against this use;
F: Strong scientific evidence against this use.